The Neurovascular Thrombectomy Devices Market is set to experience significant growth over the next few years. The market is now expected to reach a market value of US$1500 million by 2031, up from US$800 million in 2024.
The surge in demand for Neurovascular Thrombectomy Devices can be attributed to several key factors:
This product will be delivered within 1-3 business days.
The surge in demand for Neurovascular Thrombectomy Devices can be attributed to several key factors:
- Increase in Neurovascular Disorders: The rise in neurovascular disorders, coupled with the growing aging population, has significantly contributed to the demand for Neurovascular Thrombectomy Devices. These devices play a crucial role in the treatment and management of neurovascular illnesses.
- Technological Advancements: The development of technologically sophisticated products has enhanced the efficacy and safety of Neurovascular Thrombectomy Devices, making them more attractive to healthcare providers and patients alike.
- Awareness Initiatives: Efforts by various government and non-profit organizations to raise awareness about neurovascular diseases and their prevention have helped drive the market for these devices. Additionally, government subsidies and supportive reimbursement policies have further incentivized market growth.
- Embolization Coils: The segment of embolic coils within the neurovascular devices market is expected to witness increased demand due to the rising occurrence of brain aneurysms and ischemic stroke. These coils are particularly beneficial for individuals at significant surgical risk, driving the need for less invasive procedures.
challenges:
- Lack of Skilled Professionals: The market's growth potential is limited by the scarcity of skilled laboratory experts needed to operate advanced Neurovascular Thrombectomy devices. The demand for medical laboratory professionals is increasing, but the number of new graduates from clinical laboratory programs is decreasing.
- High Equipment Costs: The high cost of Neurovascular Thrombectomy devices and the infrastructure required for diagnostic rooms, particularly in developing nations, pose a significant barrier to market expansion. This high cost also makes services inaccessible to many patients in low- and middle-income countries.
COVID-19 Impact
The COVID-19 pandemic had a moderate impact on the Neurovascular Thrombectomy Devices Market. Elective brain procedures were rescheduled during the pandemic to accommodate COVID-19 patients. Hospitals also postponed elective admissions and treatments, causing a decline in hospital admissions. Telemedicine became more prevalent during this time, impacting in-person treatment.Competitive Analysis
The market is highly competitive and consolidated, with several large players. Key players in the Neurovascular Thrombectomy Devices Market are actively acquiring companies to expand their product offerings and increase their share of the global market.Key Companies Profiled
- Medtronic Plc
- Stryker Corporation
- Teleflex Incorporated
- Terumo Corporation
- Johnson & Johnson Services, Inc.
- Penumbra Inc.
- Boston Scientific Corporation
- Edwards Lifesciences Corporation
- Acandis GmbH
- Argon Medical Inc
- Others.
Neurovascular Thrombectomy Devices Market Categorization
Neurovascular Thrombectomy Devices Market by Product
- Stent Retriever
- Aspiration Catheter
Neurovascular Thrombectomy Devices Market by Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa (MEA)
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Market Overview
3. Global Neurovascular Thrombectomy Devices Market Outlook, 2018 - 2031
4. North America Neurovascular Thrombectomy Devices Market Outlook, 2018 - 2031
5. Europe Neurovascular Thrombectomy Devices Market Outlook, 2018 - 2031
6. Asia Pacific Neurovascular Thrombectomy Devices Market Outlook, 2018 - 2031
7. Latin America Neurovascular Thrombectomy Devices Market Outlook, 2018 - 2031
8. Middle East & Africa Neurovascular Thrombectomy Devices Market Outlook, 2018 - 2031
9. Competitive Landscape
10. Appendix
Companies Mentioned
- Medtronic Plc
- Stryker Corporation
- Teleflex Incorporated
- Terumo Corporation
- Johnson & Johnson Services, Inc.
- Penumbra Inc.
- Boston Scientific Corporation
- Edwards Lifesciences Corporation
- Acandis GmbH
- Argon Medical Inc
Methodology
LOADING...